Worldwide Clinical Trials

Observed annually on August 1st, #WorldLungCancerDay is a day dedicated to raising awareness of lung cancer symptoms and to highlight the need for increased research funding. Globally, lung cancer is the leading cause of cancer-related deaths among all types of cancers, affecting a staggering number of lives. That’s why today is critical to educate our communities about prevention techniques and the importance of getting regular screenings for early detection. Let’s continue raising #LungCancerAwareness and advocating for increased clinical research efforts to help develop more effective treatments for patients.

When working with #HuntingtonsDisease (HD), among the most critical aspects of study success is incorporating the patients’, their family’s, and their caretaker’s perspectives into consideration for trial design. As a result, Worldwide recently conducted several qualitative interviews with those impacted. Among our findings are: ✔️ Symptom impacts on #TrialDesign ✔️ Elements that contribute to patient participation motivation ✔️ Support needs from drug developers and trialists Check out the full article to discover how to design your next HD study: https://ow.ly/86E150Wy4xA

At Worldwide, our teams come from a number of diverse backgrounds and prior career paths. We love hearing about the various ways our employees have found Worldwide, as these distinct experiences play an integral role in making our teams who they are, bringing unique and multifaceted perspectives to our company. 👨🔬👩⚕️   Please share your career journey in the comments section! 👇   🌟 At Worldwide, you’re in this line of work because you want to make a difference in patients' lives and do it alongside others who are just as passionate as you are. If you’re interested in working with a team dedicated to making the world a better place, check out our careers page for open opportunities: https://lnkd.in/eeKZP9EU

🎇 We're happy to see that our very own Simran Padam, MD, APMMC, has been spotlighted as one of the inaugural Xtalks Featured Community Members! 🎇 As the Medical Director of Medical Affairs across Oncology, Hematology, & Cell & Gene Therapy, Dr. Padam has played an integral role in the design and execution of various #ClinicalDevelopment programs at Worldwide. With expertise in medical affairs, product development, and strategic planning, Dr. Padam's inputs have been essential to ensure the successful delivery of clinical trials and compliance with regulatory requirements. 🔬

Tomorrow, July 23, 2025, the revised International Council for Harmonisation (ICH) Good Clinical Practice (GCP) E6R3 will go into effect in the EU region. 🌍   At a recent Avoca, A WCG Company panel, participants discussed how E6R3 will affect supplier qualification processes in the #ClinicalResearch industry, including changes and challenges.     Fatemeh Jami, PhD, FRQA from Worldwide highlighted how E6R3 is a natural progression of the risk-based approach established by prior revisions (E6R2). Her other takeaways from the discussion were:    👉 Organizations should focus on understanding what adequate supplier qualification entails and be proactive and transparent throughout the process. 👉 Documentation will be crucial to demonstrate due diligence, including qualification reports, audit reports, and vendor-completed questionnaires.

Today, July 16, marks #GlioblastomaAwareness Day, a moment to recognize the resilience of patients and families affected by glioblastoma. Characterized by its rapid growth and tendency to spread within the brain, this aggressive form of brain cancer can pose challenges in #ClinicalResearch. At Worldwide, we’re ready to confront these challenges and are committed to advancing treatments for glioblastoma to help bring new therapies to patients faster. We believe in the strength of the community, and together, we can help make a meaningful impact. Let’s continue to raise awareness, share stories, and advocate for improved treatments.

In the last three years, our new, state-of-the-art #BioanalyticalLab has made significant progress, thanks to our talented experts. 🔬 Hear about the growth of our large molecule lab from Connor Kenney in his interview with Bioanalysis Zone following #WRIB25! 👇

With #CardiovascularTrials changing every day, what can truly help move studies forward in the right direction?  From recruitment challenges to complex site management, today’s cardiovascular studies require more than just scientific rigor. They demand #PatientCentric design, adaptive operations, and innovative thinking from start to finish.  In our latest white paper, our experts share real-world strategies for:  🔹 Overcoming recruitment hurdles  🔹 Enhancing site management  🔹 Leveraging technology for better data and retention  🔹 Utilizing digital health, AI, & real-world data  Get your copy today: https://ow.ly/qx4W50WkHHz

At Worldwide, we’re proud to be part of a mission-driven industry, and we know that everyone has their own “why.” 🧑⚕️ Whether you’re here to help patients, advance science, grow your career, or all three, we want to hear from you. Don’t see your #1 reason? Let us know what we’re missing in the comments! 👇

We are excited to have Fatemeh Jami, PhD, FRQA as a panelist in this upcoming session! We'll be sharing key takeaways and insights after the event, so stay tuned for our recap and thoughts on the discussions that unfold. #ICH